These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21714071)

  • 1. ATP13A2 variability in Taiwanese Parkinson's disease.
    Chen CM; Lin CH; Juan HF; Hu FJ; Hsiao YC; Chang HY; Chao CY; Chen IC; Lee LC; Wang TW; Chen YT; Chen YT; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):720-9. PubMed ID: 21714071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.
    Lin CH; Tan EK; Chen ML; Tan LC; Lim HQ; Chen GS; Wu RM
    Neurology; 2008 Nov; 71(21):1727-32. PubMed ID: 19015489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTRA2 variations in Taiwanese Parkinson's disease.
    Chen CM; Wu CH; Hsieh CH; Lin CH; Chen IC; Chen YC; Lee LC; Lee CM; Tseng YC; Lee-Chen GJ; Wu YR
    J Neural Transm (Vienna); 2014 May; 121(5):491-8. PubMed ID: 24337630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis.
    Pan LS; Wang Z; Ding D; Zhu XP; Leng HL; Deng XB; Xu YM
    Int J Neurosci; 2016; 126(7):593-9. PubMed ID: 26000924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening of ATP13A2 variant with high-resolution melting analysis.
    Funayama M; Tomiyama H; Wu RM; Ogaki K; Yoshino H; Mizuno Y; Hattori N
    Mov Disord; 2010 Oct; 25(14):2434-7. PubMed ID: 20976737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
    Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
    Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP13A2 variability in Parkinson disease.
    Vilariño-Güell C; Soto AI; Lincoln SJ; Ben Yahmed S; Kefi M; Heckman MG; Hulihan MM; Chai H; Diehl NN; Amouri R; Rajput A; Mash DC; Dickson DW; Middleton LT; Gibson RA; Hentati F; Farrer MJ
    Hum Mutat; 2009 Mar; 30(3):406-10. PubMed ID: 19085912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
    Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
    Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.
    Li G; Zhang Z; Xia H; Yang X
    Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    Sato S; Li Y; Hattori N
    J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.
    Rakovic A; Stiller B; Djarmati A; Flaquer A; Freudenberg J; Toliat MR; Linnebank M; Kostic V; Lohmann K; Paus S; Nürnberg P; Kubisch C; Klein C; Wüllner U; Ramirez A
    Mov Disord; 2009 Feb; 24(3):429-33. PubMed ID: 19097176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.
    Wang D; Gao H; Li Y; Jiang S; Yang X
    Biomed Res Int; 2020; 2020():6954820. PubMed ID: 33335927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
    Xu Q; Guo H; Zhang X; Tang B; Cai F; Zhou W; Song W
    J Neurochem; 2012 Jul; 122(2):251-9. PubMed ID: 22288903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.
    Chan AY; Baum L; Tang NL; Lau CY; Ng PW; Hui KF; Mizuno Y; Kwan JY; Mok VC; Kuo SH
    J Clin Neurosci; 2013 May; 20(5):761-2. PubMed ID: 23522931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipid switch unlocks Parkinson's disease-associated ATP13A2.
    Holemans T; Sørensen DM; van Veen S; Martin S; Hermans D; Kemmer GC; Van den Haute C; Baekelandt V; Günther Pomorski T; Agostinis P; Wuytack F; Palmgren M; Eggermont J; Vangheluwe P
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9040-5. PubMed ID: 26134396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients.
    Oluwole OG; Kuivaniemi H; Abrahams S; Haylett WL; Vorster AA; van Heerden CJ; Kenyon CP; Tabb DL; Fawale MB; Sunmonu TA; Ajose A; Olaogun MO; Rossouw AC; van Hillegondsberg LS; Carr J; Ross OA; Komolafe MA; Tromp G; Bardien S
    BMC Med Genet; 2020 Feb; 21(1):23. PubMed ID: 32019516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.